Editas Medicine, Inc.
General ticker "EDIT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $256.1M (TTM average)
Editas Medicine, Inc. follows the US Stock Market performance with the rate: 26.4%.
Estimated limits based on current volatility of 3.7%: low 2.56$, high 2.76$
Factors to consider:
- Total employees count: 87 (-64.6%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Clinical trial failure, Regulatory and compliance, Need additional capital, Manufacturing contamination, Litigation risks
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.58$, 4.37$]
- 2026-12-31 to 2027-12-31 estimated range: [1.68$, 4.49$]
Financial Metrics affecting the EDIT estimates:
- Negative: with PPE of -1.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Positive: 12.78 < Shareholder equity ratio, % of 14.63 <= 25.20
- Positive: Investing cash flow per share per price, % of 72.48 > 2.08
Short-term EDIT quotes
Long-term EDIT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $78.12MM | $32.31MM | $40.52MM |
| Operating Expenses | $247.30MM | $283.47MM | $200.53MM |
| Operating Income | $-169.18MM | $-251.15MM | $-160.01MM |
| Non-Operating Income | $15.96MM | $14.06MM | $-0.05MM |
| Interest Expense | $0.00MM | $2.19MM | $6.17MM |
| R&D Expense | $177.65MM | $199.25MM | $89.95MM |
| Income(Loss) | $-153.22MM | $-237.09MM | $-160.06MM |
| Net Income(Loss)* | $-153.22MM | $-237.09MM | $-160.06MM |
| Stockholders Equity | $349.10MM | $134.27MM | $27.29MM |
| Assets | $499.15MM | $341.59MM | $186.53MM |
| Operating Cash Flow | $-132.18MM | $-210.28MM | $-165.24MM |
| Capital expenditure | $4.72MM | $8.83MM | $0.61MM |
| Investing Cash Flow | $-3.73MM | $162.15MM | $138.67MM |
| Financing Cash Flow | $118.04MM | $56.03MM | $40.47MM |
| Earnings Per Share** | $-2.02 | $-2.88 | $-1.80 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.